Post-effective amendment to a registration statement that is not immediately effective upon filing

Fair Value Measurements and Hierarchy (Tables)

v3.22.2.2
Fair Value Measurements and Hierarchy (Tables)
6 Months Ended 11 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 02, 2021
Dec. 31, 2021
Class of Warrant or Right [Line Items]      
Summary of changes in company's Level 3 fair value measurements  

Private

Warrant 

    

Placement

    

Public

    

Liabilities

Fair value as of January 1, 2021

$

$

$

Initial measurement on February 12, 2021 (including over-allotment)

 

280,875

 

10,857,917

 

11,138,792

Change in valuation inputs or other assumptions

$

71,550

$

2,002,917

$

2,074,467

Fair value as of December 2, 2021

$

352,425

$

12,860,834

$

13,213,259

 
P3 Health Partners Inc.      
Class of Warrant or Right [Line Items]      
Schedule of carrying amounts of financial instruments

    

Successor

    

June 30, 2022

    

December 31, 2021

Financial assets:

 

  

 

  

Cash

$

63,145,379

$

140,477,586

Restricted cash

 

753,920

 

356,286

Clinics fees and insurance receivables, net

 

1,931,291

 

1,090,104

Other receivables

 

261,935

 

726,903

Financial liabilities:

 

  

 

  

Accounts payable and accrued expenses

 

20,693,070

 

17,730,683

Warrants liabilities

 

5,429,009

 

11,382,826

 

Successor

Predecessor

December 31, 

December 31, 

    

2021

  

  

2020

Financial Assets:

 

  

 

  

Cash

$

140,477,586

$

36,261,104

Restricted Cash

$

356,286

$

3,641,843

Clinics Fees and Insurance Receivables, Net

$

1,090,104

$

675,954

Other Receivables

$

726,903

$

146,117

Financial Liabilities:

 

  

 

  

Accounts Payable and Accrued Expenses

$

17,730,683

$

11,793,125

Liability for Warrants

$

11,382,826

$

6,316,605

Summary of Level 3 inputs into option pricing model

The key Level 3 inputs into the option pricing model as of June 30, 2022 relating to the Private Placement Warrants to purchase Class A Common Stock were as follows:

Volatility

    

65.00

%

Risk-Free Interest rate

 

3.00

%

Exercise Price

$

11.50

Expected Term

 

4.4

Years

The key Level 3 inputs into the option pricing model as of December 31, 2021 relating to the Private Placement Warrants to purchase Class A Common Stock were as follows:

Volatility

    

60.00

%

Risk-Free Interest rate

 

1.26

%

Exercise Price

$

11.50

Expected Term

 

4.9

Years

   
Summary of changes in company's Level 3 fair value measurements

Successor

Predecessor

    

Six Months Ended June

  

  

Six Months Ended June

30, 2022

30, 2021

Beginning Balance of Private Warrant Liability

$

502,276

$

6,316,605

Mark-to-Market Adjustment for Stock Warrants

 

(344,101)

 

10,661,579

Ending Balance of Private Warrant Liability

$

158,175

$

16,978,184

 

    

Successor

 

  

Predecessor

   

December 3, 2021

  

  

    

through

Year

December 31,

January 1, 2021

Ended

2021

through

December

(Private

December 2, 2021

31, 2020

Placement

(Class D

(Class D

Warrants)

Warrants)

Warrants)

Beginning Balance

$

793,650

$

6,316,605

$

N/A

Issuance of Class D Warrants

6,316,605

Mark-to-Market Adjustment for Stock Warrants

 

(291,374)

 

7,664,869

 

Ending Balance

$

502,276

$

13,981,474

$

6,316,605

P3 Health Partners Inc. | Class D Warrants      
Class of Warrant or Right [Line Items]      
Summary of Level 3 inputs into option pricing model    

Volatility

    

65.0

%

Risk-Free Interest rate

 

0.10

%

Exercise Price

$

4.68

Expected Term

 

1.1

Years

P3 Health Partners Inc. | Private Placement Warrants      
Class of Warrant or Right [Line Items]      
Summary of Level 3 inputs into option pricing model    

Volatility

    

60.0

%  

Risk-Free Interest rate

 

1.26

%  

Exercise Price

$

11.50

 

Expected Term

 

4.9

Years